accountindependent in the wake of mega-mergers in the pharmaceutical industry from 2009, that saw Pfizer Inc gobbling up Wyeth, and Merck & Co buying Schering-Plough. A dearth in new drug development and looming patent expirations had forced the drugmakers to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Eli Lilly "very much opposed" to merger - CEO
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account